- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The Bacteriophage Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Bacteriophage Therapy sales will be xx in 2020 from Bacteriophage Therapy million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Bacteriophage Therapy market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Bacteriophage Therapy industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Bacteriophage Therapy and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Bacteriophage Therapy market is split by Route of Administration and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Route of Administration and Application. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Route of Administration, Bacteriophage Therapy market has been segmented into Oral, Topical, Parenteral, etc.
Breakdown by Application, Bacteriophage Therapy has been segmented into Organ Transplantation, Bacterial Infections, Alcoholic Hepatitis, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Bacteriophage Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Bacteriophage Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Bacteriophage Therapy market.
For Japan, this report analyses the Japan market by players, Route of Administration and Application, for the period 2015-2025.
Competitive Landscape and Bacteriophage Therapy Market Share Analysis
Bacteriophage Therapy competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Bacteriophage Therapy revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Bacteriophage Therapy revenue and market share for each player covered in this report.
The major players covered in Bacteriophage Therapy are: Armata Pharmaceuticals, Inc., Locus Biosciences, Inc., Intralytix, Inc., Eliava Biopreparations Ltd., InnoPhage, Ltd, Pherecydes Pharma, Eligo Bioscience SA, Nextbiotics, Phagelux Inc., TechnoPhage, Intodeworld, Inc., Fixed-phage Ltd., Phagomed Biopharma GmbH., ContraFect Corporation, BiomX Ltd., EnBiotix, Inc., PhagePro, Inc., Micreos BV, Phi Therapeutics, Adaptive Phage Therapeutics, Inc., etc. Among other players domestic and global, Bacteriophage Therapy market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market segment by players, this report covers
Armata Pharmaceuticals, Inc.
Locus Biosciences, Inc.
Intralytix, Inc.
Eliava Biopreparations Ltd.
InnoPhage, Ltd
Pherecydes Pharma
Eligo Bioscience SA
Nextbiotics
Phagelux Inc.
TechnoPhage
Intodeworld, Inc.
Fixed-phage Ltd.
Phagomed Biopharma GmbH.
ContraFect Corporation
BiomX Ltd.
EnBiotix, Inc.
PhagePro, Inc.
Micreos BV
Phi Therapeutics
Adaptive Phage Therapeutics, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)
Market segment by Route of Administration, covers:
Oral
Topical
Parenteral
Market segment by Application, can be divided into
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Bacteriophage Therapy
1.2 Classification of Bacteriophage Therapy by Route of Administration
1.2.1 Overview: Global Bacteriophage Therapy Revenue by Route of Administration: 2015 Versus 2019 Versus 2025
1.2.2 Global Bacteriophage Therapy Revenue Market Share by Route of Administration in 2019
1.2.3 Oral
1.2.4 Topical
1.2.5 Parenteral
1.3 Global Bacteriophage Therapy Market by Application
1.3.1 Overview: Global Bacteriophage Therapy Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Organ Transplantation
1.3.3 Bacterial Infections
1.3.4 Alcoholic Hepatitis
1.3.5 Other
1.4 Global Bacteriophage Therapy Market Size and Forecast (2015-2025)
1.5 Global Bacteriophage Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Bacteriophage Therapy Market Size by Regions (2015-2020)
1.7 Global Bacteriophage Therapy Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Bacteriophage Therapy Status and Prospect (2015-2025)
1.7.2 Europe Bacteriophage Therapy Status and Prospect (2015-2025)
1.7.3 Asia Bacteriophage Therapy Status and Prospect (2015-2025)
1.7.4 South America Bacteriophage Therapy Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Bacteriophage Therapy Status and Prospect (2015-2025)
1.8 COVID-19 Outbreak: Bacteriophage Therapy Industry Impact
1.8.1 COVID-19 Potential Implications for the Bacteriophage Therapy
1.8.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Bacteriophage Therapy
1.8.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.8.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.8.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.8.2 Opportunity Analysis in Covid-19 Crisis
1.8.3 Market Risk and Restraints
1.8.4 Market Driving Force
2 Company Profiles
2.1 Armata Pharmaceuticals, Inc.
2.1.1 Armata Pharmaceuticals, Inc. Details
2.1.2 Armata Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Armata Pharmaceuticals, Inc. SWOT Analysis
2.1.4 Armata Pharmaceuticals, Inc. Product and Services
2.1.5 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Locus Biosciences, Inc.
2.2.1 Locus Biosciences, Inc. Details
2.2.2 Locus Biosciences, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Locus Biosciences, Inc. SWOT Analysis
2.2.4 Locus Biosciences, Inc. Product and Services
2.2.5 Locus Biosciences, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Intralytix, Inc.
2.3.1 Intralytix, Inc. Details
2.3.2 Intralytix, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Intralytix, Inc. SWOT Analysis
2.3.4 Intralytix, Inc. Product and Services
2.3.5 Intralytix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eliava Biopreparations Ltd.
2.4.1 Eliava Biopreparations Ltd. Details
2.4.2 Eliava Biopreparations Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eliava Biopreparations Ltd. SWOT Analysis
2.4.4 Eliava Biopreparations Ltd. Product and Services
2.4.5 Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 InnoPhage, Ltd
2.5.1 InnoPhage, Ltd Details
2.5.2 InnoPhage, Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 InnoPhage, Ltd SWOT Analysis
2.5.4 InnoPhage, Ltd Product and Services
2.5.5 InnoPhage, Ltd Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pherecydes Pharma
2.6.1 Pherecydes Pharma Details
2.6.2 Pherecydes Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pherecydes Pharma Product and Services
2.6.4 Pherecydes Pharma Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Eligo Bioscience SA
2.7.1 Eligo Bioscience SA Details
2.7.2 Eligo Bioscience SA Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Eligo Bioscience SA Product and Services
2.7.4 Eligo Bioscience SA Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Nextbiotics
2.8.1 Nextbiotics Details
2.8.2 Nextbiotics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Nextbiotics Product and Services
2.8.4 Nextbiotics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Phagelux Inc.
2.9.1 Phagelux Inc. Details
2.9.2 Phagelux Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Phagelux Inc. Product and Services
2.9.4 Phagelux Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 TechnoPhage
2.10.1 TechnoPhage Details
2.10.2 TechnoPhage Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 TechnoPhage Product and Services
2.10.4 TechnoPhage Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Intodeworld, Inc.
2.11.1 Intodeworld, Inc. Details
2.11.2 Intodeworld, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Intodeworld, Inc. Product and Services
2.11.4 Intodeworld, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Fixed-phage Ltd.
2.12.1 Fixed-phage Ltd. Details
2.12.2 Fixed-phage Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Fixed-phage Ltd. Product and Services
2.12.4 Fixed-phage Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.13 Phagomed Biopharma GmbH.
2.13.1 Phagomed Biopharma GmbH. Details
2.13.2 Phagomed Biopharma GmbH. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Phagomed Biopharma GmbH. Product and Services
2.13.4 Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.14 ContraFect Corporation
2.14.1 ContraFect Corporation Details
2.14.2 ContraFect Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 ContraFect Corporation Product and Services
2.14.4 ContraFect Corporation Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.15 BiomX Ltd.
2.15.1 BiomX Ltd. Details
2.15.2 BiomX Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 BiomX Ltd. Product and Services
2.15.4 BiomX Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.16 EnBiotix, Inc.
2.16.1 EnBiotix, Inc. Details
2.16.2 EnBiotix, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 EnBiotix, Inc. Product and Services
2.16.4 EnBiotix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.17 PhagePro, Inc.
2.17.1 PhagePro, Inc. Details
2.17.2 PhagePro, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 PhagePro, Inc. Product and Services
2.17.4 PhagePro, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.18 Micreos BV
2.18.1 Micreos BV Details
2.18.2 Micreos BV Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Micreos BV Product and Services
2.18.3 Micreos BV Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.19 Phi Therapeutics
2.19.1 Phi Therapeutics Details
2.19.2 Phi Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Phi Therapeutics Product and Services
2.19.4 Phi Therapeutics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.20 Adaptive Phage Therapeutics, Inc.
2.20.1 Adaptive Phage Therapeutics, Inc. Details
2.20.2 Adaptive Phage Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Adaptive Phage Therapeutics, Inc. Product and Services
2.20.4 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Bacteriophage Therapy Market Size by Players (2015-2020)
3.2 Japan Bacteriophage Therapy Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Bacteriophage Therapy Players Market Share
3.3.2 Top 10 Bacteriophage Therapy Players Market Share
4 North America Market Size and Forecast by Countries
4.1 North America Bacteriophage Therapy Market Size by Countries (2015-2020)
4.2 North America Bacteriophage Therapy Market Size and Forecast by Countries (2015-2026)
4.3 United States Bacteriophage Therapy Market Size and Forecast (2015-2025)
4.4 Canada Bacteriophage Therapy Market Size and Forecast (2015-2025)
4.5 Mexico Bacteriophage Therapy Market Size and Forecast (2015-2025)
5 Europe Market Size and Forecast by Countries
5.1 Europe Bacteriophage Therapy Market Size by Countries (2015-2020)
5.2 Europe Bacteriophage Therapy Market Size and Forecast by Countries (2015-2026)
5.3 Germany Bacteriophage Therapy Market Size and Forecast (2015-2025)
5.4 France Bacteriophage Therapy Market Size and Forecast (2015-2025)
5.5 UK Bacteriophage Therapy Market Size and Forecast (2015-2025)
5.6 Russia Bacteriophage Therapy Market Size and Forecast (2015-2025)
5.7 Italy Bacteriophage Therapy Market Size and Forecast (2015-2025)
6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Bacteriophage Therapy Market Size by Regions (2015-2020)
6.2 Asia-Pacific Bacteriophage Therapy Market Size and Forecast by Regions (2015-2026)
6.3 China Bacteriophage Therapy Market Size and Forecast (2015-2025)
6.4 Japan Bacteriophage Therapy Market Size and Forecast (2015-2025)
6.5 Korea Bacteriophage Therapy Market Size and Forecast (2015-2025)
6.6 India Bacteriophage Therapy Market Size and Forecast (2015-2025)
6.7 Southeast Asia Bacteriophage Therapy Market Size and Forecast (2015-2025)
7 South America Market Size and Forecast by Countries
7.1 South America Bacteriophage Therapy Market Size by Countries (2015-2020)
7.2 South America Bacteriophage Therapy Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Bacteriophage Therapy Market Size and Forecast (2015-2025)
7.4 Argentina Bacteriophage Therapy Market Size and Forecast (2015-2025)
8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Bacteriophage Therapy Revenue by Regions (2015-2020)
8.2 Middle East & Africa Bacteriophage Therapy Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Bacteriophage Therapy Market Size and Forecast (2015-2025)
8.4 UAE Bacteriophage Therapy Market Size and Forecast (2015-2025)
8.5 Egypt Bacteriophage Therapy Market Size and Forecast (2015-2025)
8.6 South Africa Bacteriophage Therapy Market Size and Forecast (2015-2025)
9 Market Size Segment by Route of Administration
9.1 Global Bacteriophage Therapy Market Size and Forecast by Route of Administration (2015-2025)
9.1.1 Global Bacteriophage Therapy Market Size by Route of Administration (2015-2020)
9.1.2 Global Bacteriophage Therapy Market Size Forecast by Route of Administration (2020-2025)
9.2 Japan Bacteriophage Therapy Market Size and Forecast by Route of Administration (2015-2025)
9.2.1 Japan Bacteriophage Therapy Market Size by Route of Administration (2015-2020)
9.2.2 Japan Bacteriophage Therapy Market Size Forecast by Route of Administration (2020-2025)
10 Market Size Segment by Application
10.1 Global Bacteriophage Therapy Market Size and Forecast by Application (2015-2025)
10.1.1 Global Bacteriophage Therapy Market Size by Application (2015-2020)
10.1.2 Global Bacteriophage Therapy Market Size Forecast by Application (2020-2025)
10.2 Japan Bacteriophage Therapy Market Size and Forecast by Application (2015-2025)
10.2.1 Japan Bacteriophage Therapy Market Size by Application (2015-2020)
10.2.2 Japan Bacteriophage Therapy Market Size Forecast by Application (2020-2025)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US
List of Tables
Table 1. Global Bacteriophage Therapy Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Bacteriophage Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Bacteriophage Therapy Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Bacteriophage Therapy Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Bacteriophage Therapy Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Bacteriophage Therapy Revenue Share by Regions (2015-2020)
Table 7. Global Bacteriophage Therapy Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Bacteriophage Therapy Revenue Market Share by Regions (2020-2025)
Table 9. Global Bacteriophage Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 10. Armata Pharmaceuticals, Inc. Corporate Information, Location and Competitors
Table 11. Armata Pharmaceuticals, Inc. Major Business
Table 12. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 13. Armata Pharmaceuticals, Inc. SWOT Analysis
Table 14. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product and Solutions
Table 15. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 16. Locus Biosciences, Inc. Corporate Information, Location and Competitors
Table 17. Locus Biosciences, Inc. Major Business
Table 18. Locus Biosciences, Inc. Bacteriophage Therapy Total Revenue (USD Million) (2018-2019)
Table 19. Locus Biosciences, Inc. SWOT Analysis
Table 20. Locus Biosciences, Inc. Bacteriophage Therapy Product and Solutions
Table 21. Locus Biosciences, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 22. Intralytix, Inc. Corporate Information, Location and Competitors
Table 23. Intralytix, Inc. Major Business
Table 24. Intralytix, Inc. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 25. Intralytix, Inc. SWOT Analysis
Table 26. Intralytix, Inc. Bacteriophage Therapy Product and Solutions
Table 27. Intralytix, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 28. Eliava Biopreparations Ltd. Corporate Information, Location and Competitors
Table 29. Eliava Biopreparations Ltd. Major Business
Table 30. Eliava Biopreparations Ltd. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 31. Eliava Biopreparations Ltd. SWOT Analysis
Table 32. Eliava Biopreparations Ltd. Bacteriophage Therapy Product and Solutions
Table 33. Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 34. InnoPhage, Ltd Corporate Information, Location and Competitors
Table 35. InnoPhage, Ltd Major Business
Table 36. InnoPhage, Ltd Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 37. InnoPhage, Ltd SWOT Analysis
Table 38. InnoPhage, Ltd Bacteriophage Therapy Product and Solutions
Table 39. InnoPhage, Ltd Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 40. Pherecydes Pharma Corporate Information, Location and Competitors
Table 41. Pherecydes Pharma Major Business
Table 42. Pherecydes Pharma Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 43. Pherecydes Pharma SWOT Analysis
Table 44. Pherecydes Pharma Bacteriophage Therapy Product and Solutions
Table 45. Pherecydes Pharma Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 46. Eligo Bioscience SA Corporate Information, Location and Competitors
Table 47. Eligo Bioscience SA Major Business
Table 48. Eligo Bioscience SA Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 49. Eligo Bioscience SA SWOT Analysis
Table 50. Eligo Bioscience SA Bacteriophage Therapy Product and Solutions
Table 51. Eligo Bioscience SA Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 52. Nextbiotics Corporate Information, Location and Competitors
Table 53. Nextbiotics Major Business
Table 54. Nextbiotics Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 55. Nextbiotics SWOT Analysis
Table 56. Nextbiotics Bacteriophage Therapy Product and Solutions
Table 57. Nextbiotics Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 58. Phagelux Inc. Corporate Information, Location and Competitors
Table 59. Phagelux Inc. Major Business
Table 60. Phagelux Inc. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 61. Phagelux Inc. SWOT Analysis
Table 62. Phagelux Inc. Bacteriophage Therapy Product and Solutions
Table 63. Phagelux Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 64. TechnoPhage Corporate Information, Location and Competitors
Table 65. TechnoPhage Major Business
Table 66. TechnoPhage Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 67. TechnoPhage SWOT Analysis
Table 68. TechnoPhage Bacteriophage Therapy Product and Solutions
Table 69. TechnoPhage Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 70. Intodeworld, Inc. Corporate Information, Location and Competitors
Table 71. Intodeworld, Inc. Major Business
Table 72. Intodeworld, Inc. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 73. Intodeworld, Inc. SWOT Analysis
Table 74. Intodeworld, Inc. Bacteriophage Therapy Product and Solutions
Table 75. Intodeworld, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 76. Fixed-phage Ltd. Corporate Information, Location and Competitors
Table 77. Fixed-phage Ltd. Major Business
Table 78. Fixed-phage Ltd. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 79. Fixed-phage Ltd. SWOT Analysis
Table 80. Fixed-phage Ltd. Bacteriophage Therapy Product and Solutions
Table 81. Fixed-phage Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 82. Phagomed Biopharma GmbH. Corporate Information, Location and Competitors
Table 83. Phagomed Biopharma GmbH. Major Business
Table 84. Phagomed Biopharma GmbH. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 85. Phagomed Biopharma GmbH. SWOT Analysis
Table 86. Phagomed Biopharma GmbH. Bacteriophage Therapy Product and Solutions
Table 87. Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 88. ContraFect Corporation Corporate Information, Location and Competitors
Table 89. ContraFect Corporation Major Business
Table 90. ContraFect Corporation Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 91. ContraFect Corporation SWOT Analysis
Table 92. ContraFect Corporation Bacteriophage Therapy Product and Solutions
Table 93. ContraFect Corporation Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 94. BiomX Ltd. Corporate Information, Location and Competitors
Table 95. BiomX Ltd. Major Business
Table 96. BiomX Ltd. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 97. BiomX Ltd. SWOT Analysis
Table 98. BiomX Ltd. Bacteriophage Therapy Product and Solutions
Table 99. BiomX Ltd. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 100. EnBiotix, Inc. Corporate Information, Location and Competitors
Table 101. EnBiotix, Inc. Major Business
Table 102. EnBiotix, Inc. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 103. EnBiotix, Inc. SWOT Analysis
Table 104. EnBiotix, Inc. Bacteriophage Therapy Product and Solutions
Table 105. EnBiotix, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 106. PhagePro, Inc. Corporate Information, Location and Competitors
Table 107. PhagePro, Inc. Major Business
Table 108. PhagePro, Inc. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 109. PhagePro, Inc. SWOT Analysis
Table 110. PhagePro, Inc. Bacteriophage Therapy Product and Solutions
Table 111. PhagePro, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 112. Micreos BV Bacteriophage Therapy Route of Administration and Application
Table 113. Micreos BV Major Business
Table 114. Micreos BV Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 115. Micreos BV SWOT Analysis
Table 116. Micreos BV Bacteriophage Therapy Product and Solutions
Table 117. Micreos BV Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 118. Phi Therapeutics Corporate Information, Location and Competitors
Table 119. Phi Therapeutics Major Business
Table 120. Phi Therapeutics Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 121. Phi Therapeutics SWOT Analysis
Table 122. Phi Therapeutics Bacteriophage Therapy Product and Solutions
Table 123. Phi Therapeutics Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 124. Adaptive Phage Therapeutics, Inc. Corporate Information, Location and Competitors
Table 125. Adaptive Phage Therapeutics, Inc. Major Business
Table 126. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Total Revenue (USD Million) (2017-2018)
Table 127. Adaptive Phage Therapeutics, Inc. SWOT Analysis
Table 128. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product and Solutions
Table 129. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 130. Global Bacteriophage Therapy Revenue (USD Million) by Players (2015-2020)
Table 131. Global Bacteriophage Therapy Revenue Share by Players (2015-2020)
Table 132. Key Players Bacteriophage Therapy Revenue (USD Million) in Japan (2015-2020)
Table 133. Key Players Bacteriophage Therapy Revenue Share in Japan (2015-2020)
Table 134. North America Bacteriophage Therapy Revenue (USD Million) by Countries (2015-2020)
Table 135. North America Bacteriophage Therapy Revenue Market Share by Countries (2015-2020)
Table 136. North America Bacteriophage Therapy Revenue (USD Million) by Countries (2020-2026)
Table 137. North America Bacteriophage Therapy Revenue Market Share by Countries (2020-2026)
Table 138. Europe Bacteriophage Therapy Revenue (USD Million) by Countries (2015-2020)
Table 139. Europe Bacteriophage Therapy Revenue Market Share by Countries (2015-2020)
Table 140. Europe Bacteriophage Therapy Revenue (USD Million) by Countries (2020-2026)
Table 141. Europe Bacteriophage Therapy Revenue Market Share by Countries (2020-2026)
Table 142. Asia-Pacific Bacteriophage Therapy Revenue (USD Million) by Countries (2015-2020)
Table 143. Asia-Pacific Bacteriophage Therapy Revenue Market Share by Countries (2015-2020)
Table 144. Asia-Pacific Bacteriophage Therapy Revenue (USD Million) by Countries (2020-2026)
Table 145. Asia-Pacific Bacteriophage Therapy Revenue Market Share by Countries (2020-2026)
Table 146. South America Bacteriophage Therapy Revenue (USD Million) by Countries (2015-2020)
Table 147. South America Bacteriophage Therapy Revenue Market Share by Countries (2015-2020)
Table 148. South America Bacteriophage Therapy Revenue (USD Million) by Countries (2020-2026)
Table 149. South America Bacteriophage Therapy Revenue Market Share by Countries (2020-2026)
Table 150. Middle East & Africa Bacteriophage Therapy Revenue (USD Million) by Countries (2015-2020)
Table 151. Middle East & Africa Bacteriophage Therapy Revenue Market Share by Countries (2015-2020)
Table 152. Middle East & Africa Bacteriophage Therapy Revenue (USD Million) by Countries (2020-2026)
Table 153. Middle East & Africa Bacteriophage Therapy Revenue Market Share by Countries (2020-2026)
Table 154. Global Bacteriophage Therapy Revenue (USD Million) by Route of Administration (2015-2020)
Table 155. Global Bacteriophage Therapy Revenue Share by Route of Administration (2015-2020)
Table 156. Global Bacteriophage Therapy Revenue Forecast by Route of Administration (2020-2025)
Table 157. Global Bacteriophage Therapy Market Share Forecast by Route of Administration (2020-2025)
Table 158. Japan Bacteriophage Therapy Revenue (USD Million) by Route of Administration (2015-2020)
Table 159. Japan Bacteriophage Therapy Revenue Share by Route of Administration (2015-2020)
Table 160. Japan Bacteriophage Therapy Revenue Forecast by Route of Administration (2020-2025)
Table 161. Japan Bacteriophage Therapy Market Share Forecast by Route of Administration (2020-2025)
Table 162. Global Bacteriophage Therapy Revenue (USD Million) by Application (2015-2020)
Table 163. Global Bacteriophage Therapy Revenue Share by Application (2015-2020)
Table 164. Global Bacteriophage Therapy Revenue Forecast by Application (2020-2025)
Table 165. Global Bacteriophage Therapy Market Share Forecast by Application (2020-2025)
Table 166. Japan Bacteriophage Therapy Revenue (USD Million) by Application (2015-2020)
Table 167. Japan Bacteriophage Therapy Revenue Share by Application (2015-2020)
Table 168. Japan Bacteriophage Therapy Revenue Forecast by Application (2020-2025)
Table 169. Japan Bacteriophage Therapy Market Share Forecast by Application (2020-2025)
Table 170.List of Figures
Table 171. Bacteriophage Therapy Picture
Table 172. Global Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Table 173. Global Bacteriophage Therapy Revenue Market Share by Route of Administration in 2019
Table 174. Oral Picture
Table 175. Topical Picture
Table 176. Parenteral Picture
Table 177. Bacteriophage Therapy Revenue Market Share by Application in 2019
Table 178. Organ Transplantation Picture
Table 179. Bacterial Infections Picture
Table 180. Alcoholic Hepatitis Picture
Table 181. Other Picture
Table 182. Global Bacteriophage Therapy Revenue and Growth Rate (2015-2025) (USD Million)
Table 183. Global Bacteriophage Therapy Market Size Share by Regions (2015-2025)
Table 184. Global Bacteriophage Therapy Market Size Share by Regions in 2019
Table 185. Global Bacteriophage Therapy Revenue Market Share by Regions (2020-2025)
Table 186. North America Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Table 187. Europe Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Table 188. Asia-Pacific Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Table 189. South America Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Table 190. Middle East & Africa Bacteriophage Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Table 191. Global Bacteriophage Therapy Revenue Share by Players in 2019
Table 192. Global Top 5 Players Bacteriophage Therapy Revenue Market Share in 2019
Table 193. Top 10 Players Bacteriophage Therapy Revenue Market Share in Global Market in 2019
Table 194. Global Bacteriophage Therapy Market Size (USD Million) by Route of Administration (2015-2025)
Table 195. Global Bacteriophage Therapy Market Size Share by Application (2015-2025)
Table 196. North America Bacteriophage Therapy Market Size Share by Countries (2015-2025)
Table 197. North America Bacteriophage Therapy Market Size Share by Countries in 2019
Table 198. United States Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 199. Canada Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 200. Mexico Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 201. Europe Bacteriophage Therapy Market Size Share by Countries (2015-2025)
Table 202. Europe Bacteriophage Therapy Market Size Share by Countries in 2019
Table 203. Germany Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 204. France Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 205. Russia Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 206. Italy Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 207. Spain Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 208. UK Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 209. Asia Bacteriophage Therapy Market Size Share by Countries (2015-2025)
Table 210. Asia Bacteriophage Therapy Market Size Share by Countries in 2019
Table 211. China Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 212. Japan Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 213. Korea Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 214. India Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 215. Southeast Asia Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 216. South America Bacteriophage Therapy Market Size Share by Countries (2015-2025)
Table 217. South America Bacteriophage Therapy Market Size Share by Countries in 2019
Table 218. Brazil Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 219. Argentina Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 220. Middle East & Africa Bacteriophage Therapy Market Size Share by Countries (2015-2025)
Table 221. Middle East & Africa Bacteriophage Therapy Market Size Share by Countries in 2019
Table 222. Saudi Arabia Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 223. UAE Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 224. Egypt Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 225. South Africa Bacteriophage Therapy Market Size (USD Million) and Forecast (2015-2025)
Table 226. Global Bacteriophage Therapy Revenue Share by Route of Administration (2015-2020)
Table 227. Japan Bacteriophage Therapy Revenue Share by Route of Administration (2015-2020)
Table 228. Global Bacteriophage Therapy Revenue Share by Application (2015-2020)
Table 229. Japan Bacteriophage Therapy Revenue Share by Application (2015-2020)
Please feel free to write an email to us or to use our electronic ticketing system.
